Fig. 6From: Epigenome-wide analysis of T-cell large granular lymphocytic leukemia identifies BCL11B as a potential biomarkerMethylation values over time for ten CpG sites in “patient 2” determined by bisulfite pyrosequencing. Response to therapy is indicated by descending methylation values. Sampling was not performed in a linear mannerBack to article page